2016
DOI: 10.1155/2016/5278024
|View full text |Cite
|
Sign up to set email alerts
|

Novel Mutations inMLH1andMSH2Genes in Mexican Patients with Lynch Syndrome

Abstract: Background. Lynch Syndrome (LS) is characterized by germline mutations in the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. This syndrome is inherited in an autosomal dominant pattern and is characterized by early onset colorectal cancer (CRC) and extracolonic tumors. The aim of this study was to identify mutations in MMR genes in three Mexican patients with LS. Methods. Immunohistochemical analysis was performed as a prescreening method to identify absent protein expression. PCR, Denaturing High… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…Only eight studies have reported data on Mexican-Mestizo patients with molecularly confirmed LS [ 5 , 8 , [20] , [21] , [22] , [23] , [24] , [25] ] shown in Table 4 . In the present study, the MLH1 gene (67.5 %) was more frequently affected than MSH2 (22.5 %).…”
Section: Discussionmentioning
confidence: 99%
“…Only eight studies have reported data on Mexican-Mestizo patients with molecularly confirmed LS [ 5 , 8 , [20] , [21] , [22] , [23] , [24] , [25] ] shown in Table 4 . In the present study, the MLH1 gene (67.5 %) was more frequently affected than MSH2 (22.5 %).…”
Section: Discussionmentioning
confidence: 99%
“…Lynch syndrome (LS) (OMIM #120435) is associated with variants in MLH1 [137],MSH2 [138],MSH6 [68], and/or PMS2 [139]. These variants contribute to the onset of multiple cancers including endometrial [96], breast [140], colorectal [141], and prostate [142].…”
Section: Lynch Syndromementioning
confidence: 99%
“…While various studies have identified germline pathogenic variants associated with hereditary cancer syndromes in the Mexican population, there is currently no information on genetic alterations specifically focused on Mexicans who self-identify as AJ (Torres-Mejía et al, 2015;Villarreal-Garza et al, 2015;Moreno-Ortiz et al, 2016;Quezada Urban et al, 2018;Gallardo-Rincón et al, 2020). The lack of this information remains an important limitation to further evaluate the implications of identifying high risk populations in genomic testing and public health policies in Mexico.…”
Section: Introductionmentioning
confidence: 99%